S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Anebulo Pharmaceuticals (ANEB) Institutional Ownership

$3.00
+0.04 (+1.35%)
(As of 04/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)

Current
Institutional Ownership
Percentage
28.40%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$696.73K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$70.89K
Get ANEB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ANEB Institutional Buying and Selling by Quarter

Anebulo Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.153,003$370K0.0%+584.8%0.597%
2/15/2024Vanguard Group Inc.153,003$370K0.0%+584.8%0.597%
1/16/2024LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509%
12/18/2023Vanguard Group Inc.22,344$68K0.0%+39.4%0.087%
11/14/2023Tower Research Capital LLC TRC 20,851$64K0.0%+241.8%0.081%
2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116%
11/10/2022Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994%
10/14/2022LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888%
7/22/2022LVW Advisors LLC700,000$3.64M0.7%N/A2.999%
8/18/2021Ikarian Capital LLC174,811$1.20M0.1%N/A0.749%
8/17/202122NW LP3,343,565$22.80M6.1%N/A14.322%
8/17/2021Boothbay Fund Management LLC19,835$135K0.0%N/A0.085%
8/13/2021Laurion Capital Management LP225,000$1.55M0.0%N/A0.964%
(Data available from 1/1/2016 forward)

ANEB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ANEB shares?

During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: LVW Advisors LLC ($1.56M), Nantahala Capital Management LLC ($1.43M), Vanguard Group Inc. ($370K), and Herr Investment Group LLC ($72K), Tower Research Capital LLC TRC ($64K).Learn more on ANEB's institutional investors.

What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors?

28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings.

Which institutional investors have been buying Anebulo Pharmaceuticals stock?

The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($700K), Nantahala Capital Management LLC ($511.07K), Vanguard Group Inc. ($267.63K), Herr Investment Group LLC ($29.64K), and Tower Research Capital LLC TRC ($14.75K).

How much institutional buying is happening at Anebulo Pharmaceuticals?

Institutional investors have bought a total of 1,523,097 shares in the last 24 months. This purchase volume represents approximately $5.84M in transactions.

Which Anebulo Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($54.33K).

How much institutional selling is happening at Anebulo Pharmaceuticals?

Institutional investors have sold a total of 54,328 shares in the last 24 months. This volume of shares sold represents approximately $140.99K in transactions.


This page (NASDAQ:ANEB) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners